One step closer to ‘female Viagra’ hitting the shelves

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

WHITE OAK, MD - Can you believe that it's been more than fifteen years since Viagra hit the market? The continued success of the little blue pill helped the drug's manufacturer Pfizer bring in 1.5 billion dollars last year alone!

Now from blue pills to pink, there's some stiff competition moving in. What people are calling "female Viagra" is officially one step closer to hitting pharmacies. The drug's real name is Flibanserin and an FDA advisory panel approved it after it was shot down twice in previous reviews. Flibanserin goes after the woman's brain to boost her libido, where as Viagra treats the physical symptoms of erectile dysfunction.

As many as one in three women have low sex drive,  so there's no doubt "female Viagra" could explode on the market.